TITLE/ABSTRACT |
Title |
1a |
Identify in the title that the paper describes the protocol for the planned development of a COS |
Page 0 |
Abstract |
1b |
Provide a structured abstract |
Page 0–1 |
INTRODUCTION |
Background and objectives |
2a |
Describe the background and explain the rationale for developing the COS, and identify the reasons why a COS is needed and the potential barriers to its implementation |
Pages 2–7 |
2b |
Describe the specific objectives with reference to developing a COS |
|
Pages 6–7 |
Scope |
3a |
Describe the health condition(s) and population(s) that will be covered by the COS |
Pages 2–5 |
3b |
Describe the intervention(s) that will be covered by the COS |
|
Pages 2–7 |
3c |
Describe the context of use for which the COS is to be applied |
|
Pages 6–7 |
METHODS |
Stakeholders |
4 |
Describe the stakeholder groups to be involved in the COS development process, the nature of and rationale for their involvement and also how the individuals will be identified; this should cover involvement both as members of the research team and as participants in the study |
Pages 14, 17–20 |
Information sources |
5a |
Describe the information sources that will be used to identify the list of outcomes. Outline the methods or reference other protocols/papers |
Pages 9–16 |
5b |
Describe how outcomes may be dropped/combined, with reasons |
|
Pages 16–20 |
Consensus process |
6 |
Describe the plans for how the consensus process will be undertaken |
Pages 16–20 |
Consensus definition |
7a |
Describe the consensus definition |
Page 18 |
7b |
Describe the procedure for determining how outcomes will be added/combined/dropped from consideration during the consensus process |
|
Pages 16–20 |
ANALYSIS |
Outcome scoring/feedback |
8 |
Describe how outcomes will be scored and summarised, describe how participants will receive feedback during the consensus process |
Pages 17–18 |
Missing data |
9 |
Describe how missing data will be handled during the consensus process |
Pages 17–18 |
ETHICS and DISSEMINATION |
Ethics approval/informed consent |
10 |
Describe any plans for obtaining research ethics committee/institutional review board approval in relation to the consensus process and describe how informed consent will be obtained (if relevant) |
Page 26 |
Dissemination |
11 |
Describe any plans to communicate the results to study participants and COS users, inclusive of methods and timing of dissemination |
Pages 19–20 |
ADMINISTRATIVE INFORMATION |
Funders |
12 |
Describe sources of funding, role of funders |
Page 26 |
Conflicts of interest |
13 |
Describe any potential conflicts of interest within the study team and how they will be managed |
Page 26 |